HRASF(HRASF)
HRASF
No analyst ratings available
No analyst price targets available for HRASF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $13.07B | $13.30B | $13.64B | $13.29B |
| Low | $12.34B | $13.04B | $13.13B | $12.79B |
| High | $13.65B | $13.81B | $14.20B | $13.84B |
| EBITDA Avg | $1.50B | $1.56B | $1.62B | $1.63B |
| Low | $1.47B | $1.53B | $1.58B | $1.59B |
| High | $1.54B | $1.60B | $1.66B | $1.67B |
| EBIT Avg | $863M | $896M | $928M | $922M |
| Low | $831M | $862M | $892M | $887M |
| High | $899M | $934M | $967M | $961M |
| Net Income Avg | $459M | $482M | $504M | $500M |
| Low | $437M | $458M | $479M | $475M |
| High | $484M | $508M | $531M | $526M |
| EPS Avg | $0.31 | $0.33 | $0.34 | $0.34 |
| Low | $0.30 | $0.31 | $0.33 | $0.32 |
| High | $0.33 | $0.35 | $0.36 | $0.36 |
| Analysts (Rev / EPS) | 4 / 1 | 5 / 1 | 1 / 1 | 2 / 1 |